文献速递姑息放疗与转移瘤

骨转移管理中单次与短程放疗方案的使用模式

Utilization Patterns of Single-Fraction and Short-Course Radiotherapeutic Schedules in the Management of Bone Metastases.
PubMed 文献 · Adv Radiat Oncol · 2023-01-14

该回顾性分析查询2016至2020年电子病历,纳入1004例患者共1768处骨转移灶,评估短程与单次放疗使用趋势。短程放疗从2016年40%升至2020年50%,单次放疗从7%升至11%。学术中心治疗、较近治疗年份、年龄>76岁及非脊柱部位是短程放疗预测因素。

要点

  • 短程放疗使用率从2016年40%升至2020年50%,单次放疗从7%升至11%。
  • 学术中心治疗与短程及单次放疗均相关,2010年后完成住院医师培训的医师更倾向单次放疗。
  • 年龄>76岁和非脊柱部位是短程放疗预测因素,脊柱为最常见治疗部位。

核心结论

  • 本医疗系统内骨定向短程与单次放疗使用率随时间增加。
  • 学术中心治疗与短程及单次方案均相关,2010年后完成住院医师培训的医师更可能实施单次放疗。

研究设计与样本

  • 回顾性分析,查询2016至2020年电子病历(MOSAIQ),纳入接受姑息放疗的骨转移患者。
  • 纳入接受>10次分割或Medicare批准的姑息放疗方案(30 Gy/10次、24 Gy/6次、20 Gy/5次、8 Gy/1次)的患者。
  • 治疗科室分为学术中心(n=2)与社区中心(n=12),短程治疗定义为<6次分割,长程为>10次分割。
  • 共识别1004例患者、1768处骨转移灶,采用多变量逻辑回归分析短程与单次治疗的预测因素。

主要发现

  • 脊柱为最常见部位,其次为骨盆/髋部、四肢和其他部位。
  • 短程放疗使用率从2016年40%升至2020年50%,单次放疗从2016年7%升至2020年11%。
  • 短程放疗预测因素包括学术中心治疗、较近治疗年份、患者年龄>76岁及非脊柱解剖部位。
  • 单次放疗预测因素包括学术中心治疗、治疗医师2010年后完成住院医师培训、患者年龄>76岁及四肢或其他部位治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Bone metastases are common, occurring in 60% to 70% of patients with advanced malignancies. Historically, bone-directed radiation therapy regimens of 30 Gy over 10 fractions were used. However, prospective randomized data suggest equivalent pain relief with shorter-course regimens. The American Society for Radiation Oncology Choosing Wisely Campaign encourages clinicians to consider shorter-course palliative regimens in patients with limited prognosis. A retrospective analysis was performed to assess patterns of short-course and single-fraction radiation therapy during the past 5 years. METHODS AND MATERIALS: We queried our electronic medical record (MOSAIQ) from 2016 to 2020 for patients with bone metastases who received palliative radiation therapy. Patients receiving >10 fractions or Medicare-approved palliative courses of radiation (30 Gy/10 fractions, 24 Gy/6 fractions, 20 Gy/5 fractions, 8 Gy/1 fraction) were included. Treatment department was defined as academic (n = 2) versus community (n = 12). Short-course treatment was defined as <6 fractions, whereas long-course included patients receiving >10 fractions. Patients were subdivided based on age and disease site. Physicians were grouped according to their year of residency completion. Multivariable logistic regression analysis identified predictors of short-course and single-fraction treatment. RESULTS: We identified 1004 patients with 1768 bony metastases meeting inclusion criteria. The spine was the most common site, followed by pelvis/hip, extremity, and other site. Use of short-course treatment increased from 40% in 2016 to 50% in 2020. Single-fraction treatment increased from 7% in 2016 to 11% in 2020. Predictors of shorter courses included treatment at academic centers, more recent treatment, patient age >76 years, and nonspine anatomic site. Predictors of single-fraction treatment included treatment at academic centers, treating physician residency completion after 2010, patient age >76 years, and treatment to extremity or other site. CONCLUSIONS: Rates of short-course and single-fraction bone-directed radiation therapy increased within our health system over time. Treatment receipt at academic centers was associated with both short-course and single-fraction regimens. Physicians completing residency after 2010 were more likely to deliver single-fraction therapy.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Koduri S, Abel S, Bergin J, et al. Utilization Patterns of Single-Fraction and Short-Course Radiotherapeutic Schedules in the Management of Bone Metastases. Adv Radiat Oncol. 2023. PMID: 36846440. doi:10.1016/j.adro.2023.101176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。